18.0 million from Baht 151.1 million in 2018 to be Baht 133.1 million, or 11.97% decreased. This was due to an increase in Allowance for doubtful accounts of Baht 21.8 million in 2018 whereas there was a
those businesses. Furthermore, crowdfunding regulations have recently be enacted in support of new fundraising channel in the wave of global trend whereas private equity trust has been introduced as a
to the Notification on Connected Transactions. Whereas the establishment of the Subsidiary is completed, the company will announce the news via the Stock Exchange of Thailand. บริษัท ดีโอดี ไบโอเทค จ ำ
before interest and tax decreased by Baht 87.91 million whereas corporate tax decreased by 18.56 million, financial cost slightly increased by Baht 0.72 million and profit sharing to minority shareholders
automotive pipes. This is also due to better production efficiency along the year. The profit before interest and tax increased by Baht 61.74 million whereas corporate tax increased by 13.63 million, financial
corresponding period last year. This was largely due to a rise in administrative expenses and, partially, an increase in the selling expenses of the domestic business aligning to the activities’ timeline. Whereas
revenue from sales – net was approximate to the same period last year by slightly increased by 0.10 percent whereas the total revenue was in line with by slightly decreased by 0.38 percent even under the
, increasing by 88% from last year (YE 2016: THB 1,286 million). Whereas the separate financial statement presented the impairment of investment in subsidiary company is THB 1,376 million. The loss for the